The objective of this Expert Consensus Statement is to assist clinicians in achieving remission of type 2 diabetes (T2D) in adults using diet as a primary intervention.
Using a modified Delphi process, panel members expressed levels of agreement with the statements, resulting in classification as consensus, near-consensus, or non-consensus. Results. After three iterations of the Delphi survey, 69 statements met the criteria for consensus, five for near consensus, and 60 for no consensus. Consensus was reached on several key issues: (a) Remission of T2D requires achieving, for a specified minimum time, normal glycemic measures, defined as HbA1c <6.5% and normal fasting blood glucose with no metabolic surgical interventions, endoscopic weight-loss devices, or active pharmacologic therapy for the specific purpose of lowering blood glucose; (b) Diet as a primary intervention for T2D can achieve remission in many adults with T2D and is related to the intensity of the intervention; and (c) Diet as a primary intervention for T2D is most effective in achieving remission when emphasizing whole, plant-based foods with minimal consumption of meat and other animal products.
Clinicians can use these statements to improve quality of care, inform policy and protocols, and identify areas of uncertainty.
Read article on Sage
Sign in to take quiz and track your certificates
AMA members receive a 10% discount on ACLM CME courses.
Sign in here with your AMA credentials to redeem your discount code.
The American College of Lifestyle Medicine (ACLM) is a medical professional society that provides high-quality, evidence-based education and certification prerequisites in the clinical practice of lifestyle medicine.
Rush University Medical Center designates this enduring material for a maximum of 1.0 nursing contact hour.
Disclosure Statement: As a provider of continuing education, Rush University Medical Center asks everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Mechanisms are in place to identify and mitigate any potential conflicts of interest prior to the start of the activity. All information disclosed must be shared with the participants/learners prior to the start of the educational activity.
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
Individuals in control of content for this activity have stated they have no relevant financial relationships to disclose.
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Rush University Medical Center designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Rush University Medical Center is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Upon completion of this activity, learners will receive 1.00 ANCC contact hour(s).
You currently have no searches saved.
You currently have no courses saved.